These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35803214)

  • 41. Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis.
    Caforio M; Sorino C; Iacovelli S; Fanciulli M; Locatelli F; Folgiero V
    J Exp Clin Cancer Res; 2018 Sep; 37(1):239. PubMed ID: 30261904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA-driven JAZF1-SUZ12 gene fusion in human endometrial stromal cells.
    Gupta SK; Jea JD; Yen L
    PLoS Genet; 2021 Dec; 17(12):e1009985. PubMed ID: 34928964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
    Ferraiuolo M; Verduci L; Blandino G; Strano S
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription.
    Li KK; Lee KA
    Oncogene; 1998 Mar; 16(10):1325-31. PubMed ID: 9546434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [PML (promyelocytic leukemia). Oncogene].
    Soussi T; de Thé H
    Bull Cancer; 1999 Feb; 86(2):133. PubMed ID: 10094521
    [No Abstract]   [Full Text] [Related]  

  • 46. The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.
    Numata A; Kwok HS; Kawasaki A; Li J; Zhou QL; Kerry J; Benoukraf T; Bararia D; Li F; Ballabio E; Tapia M; Deshpande AJ; Welner RS; Delwel R; Yang H; Milne TA; Taneja R; Tenen DG
    Nat Commun; 2018 Apr; 9(1):1622. PubMed ID: 29692408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ecDNAs personify cancer gangsters.
    Keshavarzian T; Lupien M
    Mol Cell; 2022 Feb; 82(3):500-502. PubMed ID: 35120647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromosome translocation-mediated conversion of a tumor suppressor gene into a dominant oncogene: fusion of EWS1 to WT1 in desmoplastic small round cell tumors.
    Rauscher FJ
    Curr Top Microbiol Immunol; 1997; 220():151-62. PubMed ID: 9103681
    [No Abstract]   [Full Text] [Related]  

  • 49. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.
    Stenman G
    Semin Cancer Biol; 2005 Jun; 15(3):224-35. PubMed ID: 15826837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis.
    Hunger SP
    Blood; 1996 Feb; 87(4):1211-24. PubMed ID: 8608207
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunogenicity and Immune Silence in Human Cancer.
    Yarmarkovich M; Farrel A; Sison A; di Marco M; Raman P; Parris JL; Monos D; Lee H; Stevanovic S; Maris JM
    Front Immunol; 2020; 11():69. PubMed ID: 32256484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.
    Lu H; Villafane N; Dogruluk T; Grzeskowiak CL; Kong K; Tsang YH; Zagorodna O; Pantazi A; Yang L; Neill NJ; Kim YW; Creighton CJ; Verhaak RG; Mills GB; Park PJ; Kucherlapati R; Scott KL
    Cancer Res; 2017 Jul; 77(13):3502-3512. PubMed ID: 28512244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear, not cytoplasmic, PKR maneuvers in AML.
    Oshima M; Iwama A
    Blood; 2015 Sep; 126(13):1523-4. PubMed ID: 26405214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
    Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
    Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts.
    Zucman J; Delattre O; Desmaze C; Epstein AL; Stenman G; Speleman F; Fletchers CD; Aurias A; Thomas G
    Nat Genet; 1993 Aug; 4(4):341-5. PubMed ID: 8401579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel Oncogenic RET Fusion Variant in Non-Small Cell Lung Cancer: RELCH-RET.
    Jiang H; Xiao M; Qi C; Cai S; Liu F
    J Thorac Oncol; 2020 Feb; 15(2):e27-e28. PubMed ID: 32127187
    [No Abstract]   [Full Text] [Related]  

  • 57. Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating
    Rich TA; Reckamp KL; Chae YK; Doebele RC; Iams WT; Oh M; Raymond VM; Lanman RB; Riess JW; Stinchcombe TE; Subbiah V; Trevarthen DR; Fairclough S; Yen J; Gautschi O
    Clin Cancer Res; 2019 Oct; 25(19):5832-5842. PubMed ID: 31300450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From Oncogene Interference to Neutrophil Immune Modulation.
    Bronte V
    Immunity; 2017 Oct; 47(4):613-615. PubMed ID: 29045894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.
    Sanchez G; Bittencourt D; Laud K; Barbier J; Delattre O; Auboeuf D; Dutertre M
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6004-9. PubMed ID: 18413612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of ETV6-RUNX1 Leukemia.
    Sundaresh A; Williams O
    Adv Exp Med Biol; 2017; 962():201-216. PubMed ID: 28299659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.